Publications

Detailed Information

KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methods

DC Field Value Language
dc.contributor.authorKang, Hee Gyung-
dc.contributor.authorChoi, Hyun Jin-
dc.contributor.authorHan, Kyung Hee-
dc.contributor.authorKim, Seong Heon-
dc.contributor.authorCho, Hee Yeon-
dc.contributor.authorCho, Min Hyun-
dc.contributor.authorShin, Jae Il-
dc.contributor.authorLee, Joo Hoon-
dc.contributor.authorLee, Joongyub-
dc.contributor.authorOh, Kook Hwan-
dc.contributor.authorPark, Young Seo-
dc.contributor.authorCheong, Hae Il-
dc.contributor.authorAhn, Curie-
dc.contributor.authorHa, Il-Soo-
dc.date.accessioned2017-02-09T01:21:07Z-
dc.date.available2017-02-09T01:21:07Z-
dc.date.issued2016-03-25-
dc.identifier.citationBMC Nephrology, 17(1):35ko_KR
dc.identifier.urihttps://hdl.handle.net/10371/100572-
dc.descriptionThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.ko_KR
dc.description.abstractBackground
The global prevalence of chronic kidney disease (CKD) is increasing. In children, CKD exhibits unique etiologies and can have serious impacts on childrens growth and development. Therefore, an aggressive approach to preventing the progression of CKD and its complications is imperative. To improve the understanding and management of Asian pediatric patients with CKD, we designed and launched KNOW-Ped CKD (KoreaN cohort study for Outcome in patients With Pediatric Chronic Kidney Disease), a nationwide, prospective, and observational cohort study of pediatric CKD with funding from the Korean government.

Methods/design
From seven major centers, 450 patients <20years of age with CKD stages I to V are recruited for the comprehensive assessment of clinical findings, structured follow-up, and bio-specimen collection. The primary endpoints include CKD progression, defined as a decline of estimated glomerular filtration rate by 50%, and a requirement for renal replacement therapy or death. The secondary outcomes include the development of left ventricular hypertrophy or hypertension, impairment of growth, neuropsychological status, behavioral status, kidney growth, and quality of life.

Discussion
With this study, we expect to obtain more information on pediatric CKD, which can be translated to better management for the patients.

Trial registration
NCT02165878(ClinicalTrials.gov), submitted on June 11, 2014.
ko_KR
dc.language.isoenko_KR
dc.publisherBioMed Centralko_KR
dc.subjectChronic kidney diseaseko_KR
dc.subjectCohort studyko_KR
dc.subjectDesignko_KR
dc.subjectPrognostic factorko_KR
dc.subjectAsian childrenko_KR
dc.titleKNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methodsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor강희경-
dc.contributor.AlternativeAuthor최현진-
dc.contributor.AlternativeAuthor한경희-
dc.contributor.AlternativeAuthor김성헌-
dc.contributor.AlternativeAuthor조희연-
dc.contributor.AlternativeAuthor조민현-
dc.contributor.AlternativeAuthor신재일-
dc.contributor.AlternativeAuthor이주훈-
dc.contributor.AlternativeAuthor이중엽-
dc.contributor.AlternativeAuthor오국환-
dc.contributor.AlternativeAuthor박영서-
dc.contributor.AlternativeAuthor정해일-
dc.contributor.AlternativeAuthor안규리-
dc.contributor.AlternativeAuthor하일수-
dc.identifier.doi10.1186/s12882-016-0248-0-
dc.language.rfc3066en-
dc.rights.holderKang et al.-
dc.date.updated2017-01-06T10:18:44Z-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share